Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem*, Jennifer Yost, Itziar Etxeandia-Ikobaltzeta, George M. Abraham, Janet A. Jokela, Matthew C. Miller, Mary Ann Forciea, Linda L. Humphrey, Mary Ann Forciea, Linda L. Humphrey, Adam J. Obley, Andrew Dunn, Robert M. Centor, Elie A. Akl, Thomas A. Bledsoe, Mary Ann Forciea, Ray Haeme, Janet A. Jokela, Devan L. Kansagara, Maura MarcucciMark P. Tschanz

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)'. Together they form a unique fingerprint.

Medicine & Life Sciences